Citadel Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$49.9M Buy
481,700
+412,700
+598% +$46.8M 0.01% 1361
2025
Q4
$6.96M Sell
69,000
-100,100
-59% -$10.9M ﹤0.01% 3774
2025
Q3
$20.9M Buy
169,100
+84,400
+100% +$10.5M ﹤0.01% 2271
2025
Q2
$10.2M Sell
84,700
-28,200
-25% -$3.76M ﹤0.01% 2995
2025
Q1
$16.6M Sell
112,900
-125,800
-53% -$19.2M ﹤0.01% 2240
2024
Q4
$38.8M Sell
238,700
-215,300
-47% -$35.2M 0.01% 1511
2024
Q3
$74M Sell
454,000
-32,600
-7% -$4.83M 0.01% 921
2024
Q2
$66.4M Buy
486,600
+28,400
+6% +$3.94M 0.01% 936
2024
Q1
$70.2M Sell
458,200
-279,700
-38% -$41.8M 0.01% 959
2023
Q4
$105M Buy
737,900
+176,400
+31% +$23.5M 0.02% 652
2023
Q3
$73.6M Buy
561,500
+285,800
+104% +$43.4M 0.02% 803
2023
Q2
$43.8M Sell
275,700
-107,600
-28% -$17.4M 0.01% 1153
2023
Q1
$60.7M Sell
383,300
-258,900
-40% -$38.8M 0.01% 929
2022
Q4
$90.1M Sell
642,200
-457,600
-42% -$64.9M 0.02% 703
2022
Q3
$141M Sell
1,099,800
-203,300
-16% -$29.3M 0.03% 434
2022
Q2
$184M Buy
1,303,100
+825,600
+173% +$118M 0.05% 301
2022
Q1
$66.4M Sell
477,500
-2,800
-0.6% -$429K 0.01% 907
2021
Q4
$83.7M Sell
480,300
-300,100
-38% -$50M 0.02% 782
2021
Q3
$129M Buy
780,400
+196,300
+34% +$33.8M 0.03% 535
2021
Q2
$105M Buy
584,100
+102,400
+21% +$18.7M 0.02% 641
2021
Q1
$92.9M Buy
481,700
+206,100
+75% +$39.7M 0.02% 617
2020
Q4
$55.6M Sell
275,600
-314,800
-53% -$65.1M 0.01% 876
2020
Q3
$124M Buy
590,400
+291,600
+98% +$64.9M 0.04% 351
2020
Q2
$65.5M Buy
298,800
+100,300
+51% +$20M 0.02% 628
2020
Q1
$34.4M Buy
198,500
+109,700
+124% +$18.1M 0.02% 840
2019
Q4
$13.6M Buy
88,800
+1,800
+2% +$269K 0.01% 1876
2019
Q3
$13.2M Sell
87,000
-11,200
-11% -$1.77M 0.01% 1908
2019
Q2
$15M Buy
98,200
+18,800
+24% +$2.87M 0.01% 1705
2019
Q1
$12.7M Buy
79,400
+6,000
+8% +$931K 0.01% 1782
2018
Q4
$11.3M Sell
73,400
-34,700
-32% -$5.41M 0.01% 1755
2018
Q3
$16.3M Buy
108,100
+24,200
+29% +$3.44M 0.01% 1588
2018
Q2
$11.3M Buy
83,900
+2,200
+3% +$272K 0.01% 1808
2018
Q1
$10.9M Buy
81,700
+39,400
+93% +$5.29M 0.01% 1639
2017
Q4
$6.29M Buy
42,300
+17,900
+73% +$2.44M ﹤0.01% 2198
2017
Q3
$3.22M Buy
24,400
+2,400
+11% +$322K ﹤0.01% 2826
2017
Q2
$2.93M Sell
22,000
-9,000
-29% -$1.21M ﹤0.01% 2684
2017
Q1
$4.18M Buy
31,000
+4,800
+18% +$622K ﹤0.01% 2225
2016
Q4
$3.15M Sell
26,200
-14,300
-35% -$1.69M ﹤0.01% 2445
2016
Q3
$5.07M Sell
40,500
-18,600
-31% -$2.44M 0.01% 1974
2016
Q2
$8.18M Buy
59,100
+29,200
+98% +$3.79M 0.01% 1402
2016
Q1
$3.77M Buy
29,900
+9,400
+46% +$1.19M ﹤0.01% 2030
2015
Q4
$2.6M Buy
20,500
+700
+4% +$86.9K ﹤0.01% 2481
2015
Q3
$2.29M Buy
19,800
+6,400
+48% +$718K ﹤0.01% 2776
2015
Q2
$1.39M Sell
13,400
-16,700
-55% -$1.8M ﹤0.01% 3521
2015
Q1
$3.32M Sell
30,100
-14,000
-32% -$1.52M ﹤0.01% 2475
2014
Q4
$4.6M Sell
44,100
-9,400
-18% -$940K ﹤0.01% 2063
2014
Q3
$5.14M Sell
53,500
-26,300
-33% -$2.38M 0.01% 1963
2014
Q2
$7.29M Sell
79,800
-8,600
-10% -$770K 0.01% 1523
2014
Q1
$7.78M Buy
88,400
+4,300
+5% +$377K 0.01% 1437
2013
Q4
$7.8M Buy
84,100
+15,000
+22% +$1.35M 0.01% 1379
2013
Q3
$5.65M Buy
69,100
+29,700
+75% +$2.51M 0.01% 1490
2013
Q2
$3.28M Buy
+39,400
New +$3.39M 0.01% 1979

Other funds holding CLX

Citadel Advisors's CLX Position: Q1 2026 in Review

Citadel Advisors reduced its Clorox (CLX) stake by 0.2% in Q1 2026, selling an estimated $319K and leaving 1,426,468 shares worth $148M. The position accounts for 0.02% of the portfolio, ranked #598.

Citadel Advisors first reported a position in CLX in Q2 2013 and has held it in 48 quarters since. The position peaked at $386M in Q2 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Citadel Advisors held 1,426,468 shares of Clorox worth $148M as of Q1 2026.
  • Citadel Advisors sold 2,816 Clorox shares in Q1 2026, an estimated $319K.
  • Clorox made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #598 holding.
  • Citadel Advisors first reported a position in Clorox in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's Clorox position peaked at $386M in Q2 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.